Inorganic Chemistry
Article
except transition metals, which employed the Stuttgart−Dresden−
Bonn quasi-relativistic effective-core potential and corresponding
correlation-consistent triple-ζ basis set.44,45 Calculations were
performed with the presence of a solvent reaction field of acetonitrile
produced by the conductor-like polarizable continuum model.46
Frequency calculations were performed on all geometry-optimized
structures to ensure that energy minima were achieved.
Synthesis. The proligand precursor 9,10-phenanthrenequinone
(95%) was purchased from Sigma-Aldrich, with the remaining
precursors synthesized according to literature procedures: 2,6-
bis(bromomethyl)pyridine,47 1H-phenanthro[9,10-d]imidazole,17 pyr-
ene-4,5-dione,48 and 9H-pyreno[4,5-d]imidazole.18
Synthesis of Halide Complexes. [Pd(phenC^N^phenC)Cl]OTf (1).
To a solution of L1 (0.369 mmol, 300 mg) in DMSO (12 mL) was
added Ag2O (0.368 mmol, 85.3 mg) and 3 Å molecular sieves. The
reaction vessel was covered in foil and left to stir at 50 °C for 24 h and
then left to cool to room temperature. To the resulting mixture was
added PdCl2(cod) (0.369 mmol, 105 mg) and then AgOTf (0.405
mmol, 104 mg). The mixture was left to stir for 48 h, then centrifuged,
and filtered through Celite. The solvent was removed under vacuum at
55 °C and the residue taken up in acetonitrile (5 mL). Addition to
Et2O (12 mL) yielded a light-yellow precipitate, which was isolated by
centrifugation and washed with Et2O (5 mL), MeOH (2 mL), and
Et2O (5 mL), yielding the crude product (260 mg). Purification was
achieved by successive washes with a minimum of MeOH (4 × 1 mL),
yielding a light-tan powder (160 mg, 46% yield). X-ray-quality crystals
were grown by the slow diffusion of Et2O into a concentrated 1:1
DMF/CH3CH solution at −30 °C. 1H NMR (400 MHz, (CD3)2SO):
δ 0.94 (t, J = 7.3 Hz, 6 H), 1.31−1.43 (m, 2 H), 1.55−1.68 (m, 2 H),
1.87−1.99 (m, 2 H), 2.00−2.12 (m, 2 H), 5.24−5.36 (m, 2 H), 5.48−
5.63 (m, 2 H), 6.41 (d, J = 15.9 Hz, 2 H), 6.90 (d, J = 15.4 Hz, 2 H),
7.79−7.95 (m, 8 H), 8.16 (s, 3 H), 8.57 (d, J = 8.2 Hz, 2 H), 8.99 (dt, J
= 8.4 and 0.7 Hz, 2 H), 9.07 (d, J = 8.2 Hz, 2 H), 9.08 (d, J = 8.2 Hz, 2
H). ESI-MS: m/z 792.6 ([M − OTf]+). Anal. Calcd for
C46H41ClF3N5O3PdS: C, 58.60; H, 4.38; N, 7.43. Found: C, 58.09;
H, 4.41; N, 7.19. Averaged results for repeat elemental analysis are
shown. For one attempt, the C was within error of the calculated value,
but for the other, it was below. This is accounted for by the presence
of a small amount (∼7%) of bromo species present, as shown by ESI-
MS at m/z 838 ([MBr − OTf]+), as well as some intractable DMSO (3
mol % by NMR), giving calculated values of 58.36% C, 4.38% H, and
7.39% N.
Alkylation of Polyaromatic Imidazoles. 1-Butyl-1H-phenanthro-
[9,10-d]imidazole. The compound was synthesized via a modified
literature procedure.17 Sodium hydroxide (4.40 mmol, 176 mg) was
added to a 10 mL solution of 1H-phenanthro[9,10-d]imidazole (3.99
mmol, 870 mg) in DMSO and stirred for 2 h at room temperature,
after which 1-iodobutane (4.5 mmol, 0.51 mL) was added and the
solution was heated to 50 °C overnight. Water (15 mL) was added to
the solution and extracted with diethyl ether (15 mL × 4). The organic
extracts were washed with water (15 mL × 2) and then the solvent was
removed, yielding a yellow-orange oil (899 mg). The crude product
was purified by column chromatography over SiO2 using acetone as
the eluent, collecting the second band. Upon removal of the solvent,
1
the oil crystallized as a yellow-orange solid (813 mg, 74% yield). H
NMR (300 MHz, (CD3)2CO): δ 0.98 (t, J = 7.4 Hz, 3 H), 1.48 (sxt, J
= 7.5 Hz, 2 H), 2.02 (quin, J = 7.5 Hz, 2 H), 4.78 (t, J = 7.2 Hz, 2 H),
7.55−7.79 (m, 4 H), 8.12 (s, 1 H), 8.41 (dt, J = 8.0 and 0.9 Hz, 1 H),
8.62−8.71 (m, 1 H), 8.81 (dt, J = 8.2 and 0.7 Hz, 1 H), 8.93 (dt, J =
8.2 and 0.8 Hz, 1 H).
9-Butyl-9H-pyreno[4,5-d]imidazole. The compound was synthe-
sized via a modified literature procedure.18 Sodium hydroxide (3.90
mmol, 156 mg) was added to a 12 mL solution of 9H-pyreno[4,5-
d]imidazole (3.55 mmol, 860 mg) in DMSO and stirred for 2 h at
room temperature, after which 1-iodobutane (4.0 mmol, 0.45 mL) was
added and the solution was heated to 50 °C overnight. Water (15 mL)
was added to the solution and extracted with diethyl ether (25 mL ×
5). The organic extracts were washed with water (20 mL × 2) and
dried with MgSO4, and the solvent was then removed, yielding an
orange crystalline powder (589 mg, 56% yield), which was used
[Pd(pyreC^N^pyreC)Cl]OTf (2). To a solution of L2 (0.319 mmol,
275 mg) in DMSO (12 mL) was added Ag2O (0.324 mmol, 75.1 mg)
and 3 Å molecular sieves. The reaction vessel was covered in foil, left
to stir at 55 °C for 24 h, and then left to cool to room temperature. To
the resulting mixture was added PdCl2(cod) (0.319 mmol, 99.1 mg)
and then AgOTf (0.351 mmol, 90.2 mg). The mixture was left to stir
for 56 h, then centrifuged, and filtered through Celite. The solvent was
removed under vacuum at 60 °C and the dark residue taken up in
acetonitrile (5 mL). Addition to Et2O (10 mL) yielded a yellow-
orange precipitate, which was isolated by centrifugation and washed
with Et2O (5 mL), MeOH (4 × 2 mL), and Et2O (5 mL), yielding a
tan powder (215 mg, 68% yield). The solutes from methanol washes
1
without further purification. H NMR (300 MHz, (CD3)2SO): δ 0.89
(t, J = 7.3 Hz, 3 H), 1.38 (sxt, J = 7.3 Hz, 2 H), 1.93 (quin, J = 7.2 Hz,
2 H), 4.78 (t, J = 7.1 Hz, 2 H), 8.07−8.14 (m, 2 H), 8.17 (s, 2 H),
8.19−8.27 (m, 2 H), 8.36 (s, 1 H), 8.57 (d, J = 7.6 Hz, 1 H), 8.80 (dt, J
= 7.5 and 0.6 Hz, 1 H).
1
were analyzed by NMR to track the degree of purification. H NMR
(400 MHz, (CD3)2SO): δ 0.99 (t, J = 7.4 Hz, 6 H), 1.39−1.55 (m, 2
H), 1.64−1.79 (m, 2 H), 2.09 (s, 2 H), 2.11−2.24 (m, 2 H), 5.40−5.53
(m, 2 H), 5.64−5.81 (m, 2 H), 6.53 (d, J = 15.9 Hz, 1 H), 7.12 (d, J =
15.7 Hz, 2 H), 8.18−8.38 (m, 11 H), 8.47 (d, J = 7.8 Hz, 2 H), 8.50
(d, J = 7.5 Hz, 3 H), 8.88 (d, J = 8.4 Hz, 2 H), 9.33 (d, J = 8.2 Hz, 2
H). ESI-MS: m/z 840.6 ([M − OTf]+). Anal. Calcd for
C50H41ClF3N5O3PdS: C, 60.61; H, 4.17; N, 7.07. Found: C, 57.76;
H, 4.06; N, 7.21.
Synthesis of Proligands. phenC^N^phenC·2HBr (L1). A solution
of 1-butyl-1H-phenanthro[9,10-d]imidazole (2.96 mmol, 813 mg) and
2,6-bis(bromomethyl)pyridine (1.40 mmol, 372 mg) in 20 mL of 1,4-
dioxane was heated to reflux for 84 h, during which time an off-white
precipitate was formed. The precipitate was collected by centrifuga-
tion, washed with diethyl ether (10 mL × 2), and then dried under
1
vacuum, yielding an off-white powder (732 mg, 64% yield). H NMR
Synthesis of Acetonitrilo Complexes. [Pd(phenC^N^phenC)-
(CH3CN)](OTf)2 (1-CH3CN). Complex 1 (0.050 mmol, 47 mg) was
taken up in a solvent mixture of 20 mL of 1:1 CH3CN/CH2Cl2, and
the light-yellow solution was reacted with AgOTf (0.11 mmol, 27 mg)
at room temperature overnight in the dark, forming a fine white
precipitate. The precipitate was removed by centrifugation and the
solvent removed under reduced pressure, leaving a light-yellow
residue, which was taken up in CH2Cl2 (3 mL), reprecipitated by
the addition of Et2O, washed with Et2O (2 × 3 mL), and then dried
(300 MHz, (CD3)2SO): δ 0.97 (t, J = 7.3 Hz, 6 H), 1.43 (sxt, J = 7.3
Hz, 4 H), 1.74 (quin, J = 7.4 Hz, 4 H), 4.38 (t, J = 7.4 Hz, 4 H), 6.14
(s, 4 H), 7.23 (t, J = 7.8 Hz, 2 H), 7.55 (t, J = 7.8 Hz, 2 H), 7.66 (d, J =
8.4 Hz, 2 H), 7.71−7.85 (m, 6 H), 8.05 (d, J = 8.1 Hz, 2 H), 8.20 (t, J
= 7.8 Hz, 1 H), 8.46 (d, J = 8.4 Hz, 2 H), 8.54 (d, J = 8.3 Hz, 2 H),
9.47 (s, 2 H). ESI-MS: m/z 732.8 ([M − Br]+).
pyreC^N^pyreC·2HBr (L2). A solution of 9-butyl-9H-pyreno[4,5-
d]imidazole (1.46 mmol, 436 mg) and 2,6-bis(bromomethyl)pyridine
(0.710 mmol, 188 mg) in 15 mL of 1,4-dioxane was heated to reflux
for 84 h, during which a light-colored precipitate was formed. The
precipitate was collected by centrifugation, washed with diethyl ether
(10 mL × 2), and then dried under vacuum, yielding an off-white
powder (411 mg, 67% yield). 1H NMR (300 MHz, (CD3)2SO): δ 0.98
(t, J = 7.3 Hz, 6 H), 1.44 (sxt, J = 7.4 Hz, 4 H), 1.71 (quin, J = 7.4 Hz,
4 H), 4.25 (t, J = 7.5 Hz, 4 H), 6.23 (s, 4 H), 7.54 (t, J = 7.9 Hz, 2 H),
7.80−8.04 (m, 14 H), 8.20 (dt, J = 7.3 and 0.8 Hz, 2 H), 8.29 (t, J =
7.8 Hz, 1 H), 9.58 (s, 2 H). ESI-MS: m/z 780.9 ([M − Br]+).
1
under vacuum, yielding an off-white powder (36 mg, 66% yield). H
NMR (400 MHz, CD3CN): δ 0.98 (t, J = 7.4 Hz, 6 H), 1.37−1.51 (m,
2 H), 1.59−1.73 (m, 2 H), 1.92−2.07 (m, 4 H), 1.96 (s, 3 H), 5.00
(dt, J = 14.9 and 8.1 Hz, 2 H), 5.23 (dt, J = 14.9 and 6.2 Hz, 2 H), 6.29
(d, J = 15.7 Hz, 2 H), 6.75 (d, J = 15.9 Hz, 2 H), 7.81−8.01 (m, 10 H),
8.09 (t, J = 8.0 Hz, 1 H), 8.54 (dt, J = 8.2 and 0.7 Hz, 2 H), 8.80 (dt, J
= 8.3 and 0.7 Hz, 2 H), 8.98 (d, J = 8.2 Hz, 2 H), 8.99 (d, J = 8.2 Hz, 2
H). ESI-MS: m/z 377.9 ([M − CH3CN − 2(OTf)]2+), 905.6 ([M −
CH3CN − OTf]+).
J
Inorg. Chem. XXXX, XXX, XXX−XXX